Precision Optics Corp Inc (POCI)
5.60
-0.05
(-0.89%)
USD |
NASDAQ |
May 02, 12:36
Precision Optics SG&A Expense (Quarterly): 1.933M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.933M |
September 30, 2023 | 1.656M |
June 30, 2023 | 2.042M |
March 31, 2023 | 2.023M |
December 31, 2022 | 1.873M |
September 30, 2022 | 1.496M |
June 30, 2022 | 1.639M |
March 31, 2022 | 1.574M |
December 31, 2021 | 1.467M |
September 30, 2021 | 0.9336M |
June 30, 2021 | 1.044M |
March 31, 2021 | 0.928M |
December 31, 2020 | 0.9212M |
September 30, 2020 | 0.822M |
June 30, 2020 | 0.788M |
March 31, 2020 | 0.9626M |
December 31, 2019 | 1.241M |
September 30, 2019 | 0.9078M |
June 30, 2019 | 0.6707M |
March 31, 2019 | 0.4145M |
December 31, 2018 | 0.3559M |
September 30, 2018 | 0.6605M |
June 30, 2018 | 0.4189M |
March 31, 2018 | 0.3886M |
December 31, 2017 | 0.27M |
Date | Value |
---|---|
September 30, 2017 | 0.2966M |
June 30, 2017 | 0.3099M |
March 31, 2017 | 0.3186M |
December 31, 2016 | 0.3425M |
September 30, 2016 | 0.3438M |
June 30, 2016 | 0.3724M |
March 31, 2016 | 0.4074M |
December 31, 2015 | 0.4071M |
September 30, 2015 | 0.365M |
June 30, 2015 | 0.441M |
March 31, 2015 | 0.4105M |
December 31, 2014 | 0.3468M |
September 30, 2014 | 0.3471M |
June 30, 2014 | 0.3573M |
March 31, 2014 | 0.4432M |
December 31, 2013 | 0.3669M |
September 30, 2013 | 0.336M |
June 30, 2013 | 0.3611M |
March 31, 2013 | 0.3502M |
December 31, 2012 | 0.2689M |
September 30, 2012 | 0.281M |
June 30, 2012 | 0.3497M |
March 31, 2012 | 0.3099M |
December 31, 2011 | 0.2747M |
September 30, 2011 | 0.2534M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.6707M
Minimum
Jun 2019
2.042M
Maximum
Jun 2023
1.312M
Average
1.241M
Median
Dec 2019
SG&A Expense (Quarterly) Benchmarks
AptarGroup Inc | 152.78M |
Daxor Corp | -- |
Sanara MedTech Inc | 16.34M |
Warby Parker Inc | 108.64M |
Perspective Therapeutics Inc | 1.694M |